Anacor Pharma (ANAC) Files $86.25M IPO

September 13, 2010 9:59 AM EDT Send to a Friend
Anacor Pharmaceuticals, Inc. (Nasdaq: ANAC) filed a registration statement with the U.S. Securities and Exchange Commission today for an Initial Public Offering of its common stock. The proposed maximum aggregate offering price is $86.25 million. The company plans to list their shares on The NASDAQ Global Market under the ticker “ANAC.”

The offering is being made through Citi, Deutsche Bank, Cowen and Company, and Wedbush PacGrow Life Sciences.

Anacor Pharma is a biopharmaceutical company focused on discovering, developing and commercializing novel small-molecule therapeutics derived from their boron chemistry platform.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

IPOs

Related Entities

Deutsche Bank, Citi, Cowen & Co

Add Your Comment